Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Practice Guideline
PubMed
29119666
DOI
10.1111/jth.13867
PII: S1538-7836(22)04418-X
Knihovny.cz E-resources
- MeSH
- Models, Biological * MeSH
- Factor IX administration & dosage pharmacokinetics MeSH
- Factor VIII administration & dosage pharmacokinetics MeSH
- Hemophilia A blood diagnosis drug therapy MeSH
- Hemophilia B blood diagnosis drug therapy MeSH
- Blood Coagulation drug effects MeSH
- Clinical Decision-Making MeSH
- Coagulants administration & dosage pharmacokinetics MeSH
- Humans MeSH
- Decision Support Techniques MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Practice Guideline MeSH
- Names of Substances
- Factor IX MeSH
- Factor VIII MeSH
- Coagulants MeSH
Department of Medicine McMaster University Hamilton Ontario Canada
Department of Pediatric Hematology University Hospital Brno Brno Czech Republic
St Jude Children's Research Hospital Memphis TN USA
Van Creveldkliniek University Medical Center Utrecht the Netherlands
References provided by Crossref.org
First experience of a hemophilia monitoring platform: florio HAEMO
